Search

everythinglearnresearchcommunity

for

Search:↓

Chromosomal microarray analysis is important for diagnosing rare genetic variations and guiding treatment.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

Basal cell carcinoma cases are rising globally.

New treatments for a type of skin cancer show promise but have side effects and may work better with other therapies.

Some Greek melanoma patients have gene mutations linked to increased cancer risk, a new color feature helps diagnose melanoma, the incidence of a skin condition in the Netherlands is rare, and a gene possibly affects male-pattern baldness.

Immune cells boost stem cell activity in hairy moles, causing more hair growth.

The document doesn't provide a clear conclusion or detailed findings about the impact of certain cells on cancer treatment.

NCSTN gene mutation causes abnormal skin cell differentiation and more inflammation, contributing to Hidradenitis Suppurativa.

Using the drugs AMD3100 and Tacrolimus together greatly improves skin healing and hair growth after a deep skin cut by increasing stem cells in the wound.

Low CD4 counts in HIV patients are linked to more skin disorders.

CD34 is a marker for isolating stem-like cells in mouse hair follicles.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

Biological therapy boosts the immune system to effectively fight melanoma.

Skin cells can naturally limit the growth of cancerous changes by balancing cell renewal and differentiation.

Adding TERT and BMI1 to certain skin cells can improve their ability to create hair follicles in mice.

Overexpressing Merkel cell virus proteins in human hair follicles can create clusters of cells that resemble Merkel cell cancer.

CD34+ hair follicle stem cells can become melanin-producing cells for treating skin conditions.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Targeting cholesterol, fatty acids, fibrosis, and mast cells may help treat CCCA.

The CUBIC protocol allows detailed 3D visualization of proteins in mouse skin biopsies.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

CEC levels may be a useful marker for predicting prostate cancer progression.

Inhibiting HSP90 increases cell adaptability and survival under stress.

Bimekizumab quickly improves psoriasis symptoms and skin at the molecular level.

Basonuclin 1 (BNC1) helps skin cells multiply and move, which is crucial for wound healing.